Next Article in Journal
Cationic Dendrimer G2-S16 Inhibits Herpes Simplex Type 2 Infection and Protects Mice Vaginal Microbiome
Previous Article in Journal
Development of a Sustained Release Nano-In-Gel Delivery System for the Chemotactic and Angiogenic Growth Factor Stromal-Derived Factor 1α
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 12
Issue 6
10.3390/pharmaceutics12060514
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Erratum to Pharmaceutics 2019, 11(11), 587.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587

by
Ina Puscas
1,†,
Florian Bernard-Patrzynski
1,†,
Martin Jutras
1,
Marc-André Lécuyer
2,3,
Lyne Bourbonnière
2,
Alexandre Prat
2,
Grégoire Leclair
1,* and
V. Gaëlle Roullin
1,*
1
Faculty of Pharmacy, Université de Montréal, CP6128 Succursale Centre-ville, Montreal, QC H3C 3J7, Canada
2
Department of Neuroscience, Faculty of Medicine, Université de Montréal and Centre de Recherc and du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada
3
Centre for Biostructural Imaging of Neurodegeneration, Institute for Multiple Sclerosis Research and Neuroimmunology, University Medical Center Göttingen, 37075 Göttingen, Germany
*
Authors to whom correspondence should be addressed.
†
These authors equally contributed to this work.
Pharmaceutics 2020, 12(6), 514; https://doi.org/10.3390/pharmaceutics12060514
Submission received: 26 May 2020 / Accepted: 2 June 2020 / Published: 4 June 2020
Browse Figure
Versions Notes
The authors wish to make the following corrections to this paper [1]:
The version of Figure 3a that was uploaded with the manuscript was based on a calculation error, whereas the publication text referred to the correct version of Figure 3a. After the publication of this work, we noted the mistake and issued an erratum on the y-axis. Figure 3a has now been corrected in this erratum.
The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

  1. Puscas, I.; Bernard-Patrzynski, F.; Jutras, M.; Lécuyer, M.-A.; Bourbonnière, L.; Prat, A.; Leclair, G.; Roullin, V.G. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Pharmaceutics 12 00514 g001 550
Figure 3. (a) Transendothelial electrical resistance (TEER, expressed as Ω × cm2) and (b) endothelial Pe for sodium fluorescein (NaFl) and FITC-dextran (Pe, expressed in cm/s) of the blood–brain barrier models built from mouse primary brain endothelial cells (BMEC, blue) and from mouse brain endothelial cell line (bEnd.3, red) at day 7. All data are presented as means ± SD (n = 12 for TEER, n = 4 for Pe). Statistical analysis: unpaired t test with Welch’s correction (ns: p ≥ 0.0332, **** p < 0.0001, ND- not detected).
Figure 3. (a) Transendothelial electrical resistance (TEER, expressed as Ω × cm2) and (b) endothelial Pe for sodium fluorescein (NaFl) and FITC-dextran (Pe, expressed in cm/s) of the blood–brain barrier models built from mouse primary brain endothelial cells (BMEC, blue) and from mouse brain endothelial cell line (bEnd.3, red) at day 7. All data are presented as means ± SD (n = 12 for TEER, n = 4 for Pe). Statistical analysis: unpaired t test with Welch’s correction (ns: p ≥ 0.0332, **** p < 0.0001, ND- not detected).
Pharmaceutics 12 00514 g001

Share and Cite

MDPI and ACS Style

Puscas, I.; Bernard-Patrzynski, F.; Jutras, M.; Lécuyer, M.-A.; Bourbonnière, L.; Prat, A.; Leclair, G.; Roullin, V.G. Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587. Pharmaceutics 2020, 12, 514. https://doi.org/10.3390/pharmaceutics12060514

AMA Style

Puscas I, Bernard-Patrzynski F, Jutras M, Lécuyer M-A, Bourbonnière L, Prat A, Leclair G, Roullin VG. Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587. Pharmaceutics. 2020; 12(6):514. https://doi.org/10.3390/pharmaceutics12060514

Chicago/Turabian Style

Puscas, Ina, Florian Bernard-Patrzynski, Martin Jutras, Marc-André Lécuyer, Lyne Bourbonnière, Alexandre Prat, Grégoire Leclair, and V. Gaëlle Roullin. 2020. "Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics 2019, 11, 587" Pharmaceutics 12, no. 6: 514. https://doi.org/10.3390/pharmaceutics12060514

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop